BD Diagnostics said this week that it has filed for 510(k) clearance with the US Food and Drug Administration for its BD ProbeTec HSV-1 and HSV-2 Qx Amplified DNA assays.

The assays will run on the BD Viper system with XTR technology, which uses strand displacement amplification to qualitatively detect and differentiate herpes simplex virus I and II DNA in clinician-collected external anogenital lesion specimens.

BD said that its tests will allow laboratories to read up to 96 positive or negative results in about two and a half hours

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.